6 days ago
CLYM
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Analyst Ranking
Top 2%
#65 out of 5507 analysts
Average Return
+48.44%
Win Rate
57%96 out of 167
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Climb Bio IncCLYM | +715.38% | $1.95 | $15.90 | 2025-10-16 - 2026-09-08 | Strong Buy |
Climb Bio IncCLYM | +691.04% | $2.01 | $15.90 | 2025-09-30 - 2026-09-08 | Strong Buy |
Climb Bio IncCLYM | +585.34% | $2.32 | $15.90 | 2025-09-22 - 2026-09-08 | Strong Buy |
Spyre Therapeutics IncSYRE | +512.62% | $14.82 | $90.79 | 2025-09-16 - 2026-09-08 | Strong Buy |
Oruka Therapeutics IncORKA | +481.80% | $16.21 | $94.31 | 2025-09-17 - 2026-09-08 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
a month ago
CGEM
2 months ago
ABVX
3 months ago
SYRE
3 months ago
CLYM
3 months ago
RZLT
4 months ago
INVA
4 months ago
CLYM
4 months ago
AVTX
4 months ago
ORKA
5 months ago
SYRE
5 months ago
ORKA
6 months ago
JBIO
7 months ago
NKTR
8 months ago
ARDX
8 months ago
ABVX
8 months ago
APGE
8 months ago
APGE
9 months ago
TBPH
10 months ago
CGEM
10 months ago
RNAC
10 months ago
ORKA
a year ago
ABVX
a year ago
CLYM
a year ago
MAZE
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | 12 | Strong Buy | $121.00 | +33.27% | Reiterates | 18 hours ago |
Climb Bio IncCLYM | 8 | Strong Buy | $32.00 | +101.26% | Maintains | 6 days ago |
Outlook Therapeutics IncOTLK | 8 | Strong Buy | $4.00 | +525.00% | Reiterates | a month ago |
Liquidia CorpLQDA | 10 | Strong Buy | $111.00 | +64.01% | Maintains | a month ago |
Apogee Therapeutics IncAPGE | 8 | Hold | N/A | N/A | Downgrades | a month ago |
Maze Therapeutics IncMAZE | 7 | Strong Buy | $46.00 | +74.44% | Reiterates | a month ago |
Oruka Therapeutics IncORKA | 10 | Strong Buy | $151.00 | +60.11% | Reiterates | a month ago |
Mereo Biopharma Group PLCMREO | 5 | Strong Buy | $1.00 | +292.16% | Reiterates | a month ago |
Jade Biosciences IncJBIO | 8 | Strong Buy | $77.00 | +295.89% | Maintains | a month ago |
Ardelyx IncARDX | 4 | Strong Buy | $14.00 | +271.35% | Maintains | a month ago |
Yarrow Bioscience IncYARW | 2 | Strong Buy | $58.00 | +97.95% | Initiates Coverage On | a month ago |
Tvardi Therapeutics IncTVRD | 4 | Strong Buy | $5.00 | +157.73% | Maintains | a month ago |
Cullinan Therapeutics IncCGEM | 6 | Strong Buy | $39.00 | +79.81% | Maintains | a month ago |
Abivax SaABVX | 8 | Strong Buy | $175.00 | +47.12% | Maintains | 2 months ago |
Theravance Biopharma IncTBPH | 7 | Hold | N/A | N/A | Downgrades | 2 months ago |
Innoviva IncINVA | 5 | Strong Buy | $42.00 | +96.81% | Maintains | 3 months ago |
Avalo Therapeutics IncAVTX | 6 | Strong Buy | $58.00 | +194.27% | Reiterates | 3 months ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $44.00 | +391.62% | Reiterates | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 7 | Strong Buy | $30.00 | +100.80% | Reiterates | 3 months ago |
Rezolute IncRZLT | 6 | Strong Buy | $6.00 | +36.36% | Maintains | 3 months ago |
Nektar TherapeuticsNKTR | 5 | Strong Buy | $178.00 | +135.95% | Maintains | 5 months ago |
Akebia Therapeutics IncAKBA | 5 | Strong Buy | $4.00 | +288.35% | Reiterates | 5 months ago |
Connect Biopharma Holdings LtdCNTB | 4 | Strong Buy | $10.00 | +423.56% | Reiterates | 5 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +163.27% | Reiterates | 10 months ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -43.81% | Reiterates | 10 months ago |
Keros Therapeutics IncKROS | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Anaptysbio IncANAB | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aclaris Therapeutics IncACRS | 4 | Strong Buy | $8.00 | N/A | Upgrades | 2 years ago |
Cymabay Therapeutics IncCBAY | 8 | Hold | N/A | N/A | Downgrades | 3 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 3 years ago |
Morphic Holding IncMORF | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 4 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.